Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the week’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
7. House Ways & Means considers arguments for medical device tax repeal
Medical device tax repeal advocates return to the House Ways & Means Committee to jump-start a new effort to take down the Obamacare levy.
6. Boston Scientific to present full safety results for Watchman heart implant
Boston Scientific has a change of heart, deciding to present all 3 co-primary safety and efficacy endpoints from the PREVAIL clinical trial of its Watchman stroke prevention implant.
5. The Chinese medical device market: Driven by both growth and value
China is a huge potential medical device market and companies who can focus on value may in fact be the ones best-positioned for growth.
Read more
4. Medical device tax and the iPhone: Grover Norquist’s anti-tax group jumps on new argument for repeal
First the IRS was coming for your medical device, now your iPhone too? An old tax foe jumps into the fray in the medical device tax repeal fight.
3. Report: Boston Scientific issues alert on its lead-free S-ICD defibrillator
Boston Scientific warns physicians of a potential defect in its unique subcutaneous implantable cardioverter defibrillators.
2. Medtronic pays $84M in damages for Edwards TAVI patent infringement
Medical device giant Medtronic pays the $83.6 million it owed for a transcatheter aortic valve replacement patent infringement loss to rival Edwards Lifesciences.
1. Jury deems J&J’s DePuy ASR XL hip implant defective in design, orders $8.3M in damages
Johnson & Johnson defends its DePuy subsidiary’s ASR XL hip devices after a California jury finds that the metal-on-metal implants were defectively designed, awarding plaintiff Loren Kransky $8.3 million in compensatory damages.